Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression

Neuromuscular Disorders

Volumn 24, Issue 5, 2014, Pages 393-401

  Willcocks, R J ^a   Arpan, I A ^a   Forbes, S C ^a   Lott, D J ^a   Senesac, C R ^a   Senesac, E ^a   Deol, J ^a   Triplett, W T ^a   Baligand, C ^a   Daniels, M J ^b   Sweeney, H L ^c   Walter, G A ^a   Vandenborne, K ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

30 Foot walk; Duchenne muscular dystrophy; Magnetic resonance imaging; Transverse relaxation time

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; HISTOGRAM; HUMAN; LEG MUSCLE; LONGITUDINAL STUDY; MALE; MUSCLE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; SCHOOL CHILD; SOLEUS MUSCLE; ADIPOSE TISSUE; GROWTH, DEVELOPMENT AND AGING; IMAGE PROCESSING; LEG; LOCOMOTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADOLESCENT; CHILD; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEG; LOCOMOTION; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; SEVERITY OF ILLNESS INDEX;

EID: 84899120122     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.12.012     Document Type: Article

References (30)

1. Desguerre I., Christov C., Mayer M., et al. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One 2009, 4:e4347.
2. Fraser L.K., Childs A.M., Miller M., et al. A cohort study of children and young people with progressive neuromuscular disorders: clinical and demographic profiles and changing patterns of referral for palliative care. Palliat Med 2012, 26:924-929.
3. Pichavant C., Aartsma-Rus A., Clemens P.R., et al. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 2011, 19:830-840.
4. Porter J.D., Khanna S., Kaminski H.J., et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002, 11:263-272.
5. Cros D., Harnden P., Pellissier J.F., Serratrice G. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol 1989, 236:43-47.
6. Marden F.A., Connolly A.M., Siegel M.J., Rubin D.A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34:140-148.
7. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76:346-353.
8. Torriani M., Townsend E., Thomas B.J., Bredella M.A., Ghomi R.H., Tseng B.S. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2012, 41:437-445.
9. Kim H.K., Laor T., Horn P.S., Racadio J.M., Wong B., Dardzinski B.J. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 2010, 255:899-908.
10. Weber M.A., Nagel A.M., Jurkat-Rott K., Lehmann-Horn F. Sodium (23Na) MRI detects elevated muscular sodium concentration in Duchenne muscular dystrophy. Neurology 2011, 77:2017-2024.
11. Akima H., Lott D., Senesac C., et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2012, 22:16-25.
12. Gaeta M., Messina S., Mileto A., et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments: preliminary experience. Skeletal Radiol 2012, 41:955-961.
13. Gloor M., Fasler S., Fischmann A., et al. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. J Magn Reson Imaging 2011, 33:203-210.
14. Kim H.K., Laor T., Horn P.S., Wong B. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 2010, 11:304-311.
15. Huang Y., Majumdar S., Genant H.K., et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 1994, 4:59-64.
16. Gaeta M., Scribano E., Mileto A., et al. Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification-a feasibility study. Radiology 2011, 259:487-494.
17. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging 2009, 30:1130-1138.
18. Arpan I., Forbes S.C., Lott D.J., et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-years-old boys with Duchenne muscular dystrophy. NMR Biomed 2013, 26:320-328.
19. Fischmann A., Hafner P., Fasler S., et al. Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J Neurol 2013, 259:1648-1654.
20. Gambarota G., Cairns B.E., Berde C.B., Mulkern R.V. Osmotic effects on the T2 relaxation decay of in vivo muscle. Magn Reson Med 2001, 46:592-599.
21. Friedman S.D., Poliachik S.L., Carter G.T., Budech C.B., Bird T.D., Shaw D.W. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Muscle Nerve 2012, 45:500-506.
22. Forbes S.C., Walter G.A., Rooney W.D., et al. Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 2013, 269:198-207.
23. Kobayashi M., Nakamura A., Hasegawa D., Fujita M., Orima H., Takeda S. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 2009, 40:815-826.
24. Rooney WD, Forbes S, Pollaro J, et al. Water T2 values are elevated in Duchenne muscular dystrophy independent of fat infiltration. In International Society for Magnetic Resonance in Medicine Annual Meeting. 2012. Melbourne, Australia.
25. Wansapura J.P., Hor K.N., Mazur W., et al. Left ventricular T2 distribution in Duchenne muscular dystrophy. J Cardiovasc Magn Reson 2010, 12:14.
26. Phoenix J., Betal D., Roberts N., Helliwell T.R., Edwards R.H. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996, 19:302-310.
27. Triplett W.T., Baligand C., Forbes S.C., et al. Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med 2013, 10.1002/mrm.24917.
28. Wren T.A., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190:W8-W12.
29. Janiczek R.L., Gambarota G., Sinclair C.D., et al. Simultaneous T(2) and lipid quantitation using IDEAL-CPMG. Magn Reson Med 2011, 66:1293-1302.
30. Yao L., Gai N. Fat-corrected T2 measurement as a marker of active muscle disease in inflammatory myopathy. AJR Am J Roentgenol 2012, 198:W475-W481.